Zebrafish as an emerging model for studying complex brain disorders

AV Kalueff, AM Stewart, R Gerlai - Trends in pharmacological sciences, 2014 - cell.com
The zebrafish (Danio rerio) is rapidly becoming a popular model organism in
pharmacogenetics and neuropharmacology. Both larval and adult zebrafish are currently …

Age‐related changes in cerebrovascular health and their effects on neural function and cognition: A comprehensive review

B Zimmerman, B Rypma, G Gratton… - …, 2021 - Wiley Online Library
The process of aging includes changes in cellular biology that affect local interactions
between cells and their environments and eventually propagate to systemic levels. In the …

Glutamate transporter GLT-1 as a therapeutic target for substance use disorders

DJ Roberts-Wolfe, PW Kalivas - CNS & Neurological …, 2015 - ingentaconnect.com
The development of new treatments for substance use disorders requires identification of
targetable molecular mechanisms. Pathology in glutamatergic neurotransmission system in …

Ibogaine: a review

KR Alper - 2001 - Elsevier
Publisher Summary The chapter discusses ibogaine, which is a naturally occurring plant
alkaloid with a history of use as a medicinal and ceremonial agent in West Central Africa …

Applying laboratory research: drug anticipation and the treatment of drug addiction.

S Siegel, B Ramos - Experimental and clinical …, 2002 - psycnet.apa.org
Basic research concerning drug tolerance and withdrawal may inform clinical practice, and
vice versa. Three areas that integrate the work of the laboratory and the clinic are …

Role of glutamatergic and GABAergic systems in alcoholism

KM Davis, JY Wu - Journal of Biomedical Science, 2001 - karger.com
The pharmacological effects of ethanol are complex and widespread without a well-defined
target. Since glutamatergic and GABAergic innervation are both dense and diffuse and …

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

A Bisaga, SD Comer, AS Ward, P Popik, HD Kleber… - …, 2001 - Springer
Rationale: Preclinical observations suggest that NMDA receptor-mediated glutamatergic
neurotransmission is involved in the expression and maintenance of opioid dependence …

A systematic review of off-label uses of memantine for psychiatric disorders

K Zdanys, RR Tampi - Progress in Neuro-Psychopharmacology and …, 2008 - Elsevier
Recent data points to glutamatergic dysfunction in mood disorders, anxiety disorders,
obsessive–compulsive disorder, and schizophrenia. Memantine, a drug approved by the …

Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist

P Popik, M Wrobel - Neuropharmacology, 2002 - Elsevier
In the present study we examined the effect of MPEP [2-methyl-6-(phenylethynyl)-pyridine] a
potent, selective and systemically active metabotropic glutamate receptor (mGluR) type I …

Homocysteine as a neurotoxin in chronic alcoholism

S Bleich, D Degner, W Sperling, D Bönsch… - Progress in Neuro …, 2004 - Elsevier
There is evidence from in vitro and in vivo studies that homocysteine induces neuronal
damage and cell loss by both excitotoxicity and different apoptotic processes. Clinical …